Kelan Hlavaty

Title: Innovations by Kelan Hlavaty

Introduction

Kelan Hlavaty is an accomplished inventor based in Belmont, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of immunology. With a total of two patents to his name, Hlavaty's work focuses on enhancing immune responses through innovative formulations.

Latest Patents

Hlavaty's latest patents include formulations of modified peripheral blood mononuclear cells (PBMCs). The first patent provides formulations that comprise PBMCs with at least one antigen, such as a human papillomavirus (HPV) antigen, along with a cryopreservation medium. In some embodiments, the PBMCs are conditioned by incubating them in the presence of an adjuvant. The second patent details the delivery of biomolecules to PBMCs to modify an immune response. This patent outlines methods of manufacturing PBMCs that include an antigen and describes how these cells can be used to modulate an immune response in individuals.

Career Highlights

Throughout his career, Hlavaty has worked with notable companies in the biotechnology sector. He has been associated with Stemcell Technologies Canada Inc. and Sqz Biotechnologies Company. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of immunology.

Collaborations

Hlavaty has collaborated with several professionals in his field, including Howard Bernstein and Scott Loughhead. These collaborations have likely enriched his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Kelan Hlavaty's contributions to biotechnology through his patents and collaborations highlight his role as an innovative inventor. His work in modifying immune responses through PBMC formulations is paving the way for future advancements in immunology.